Atossa Therapeutics (ATOS) EBITDA Margin (2011 - 2015)
Atossa Therapeutics (ATOS) posted EBITDA Margin of -134797.16% for Q4 2015, down 15778.43 percentage points from -119018.72% a year earlier.
Powered by 
Analysis
Atossa Therapeutics (ATOS) EBITDA Margin (2011 - 2015) Analysis & Trends
For FY2015, Atossa Therapeutics' EBITDA Margin came in at -710238.40%, down 681112.10 percentage points from FY2014.
- Annual EBITDA Margin has declined for three consecutive years, with a four-year change of -482667.26 percentage points (FY2011 to FY2015).
- In prior years, Atossa Therapeutics' EBITDA Margin was -29126.30% in FY2014 (-27496.14 pp), -1630.16% in FY2013 (-605.24 pp), -1024.92% in FY2012 (+226546.22 pp) and -227571.13% in FY2011.
- The Q4 2015 figure stands as the lowest quarterly EBITDA Margin in data going back to Q4 2011.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2012, with a gain of 77579.89 percentage points; the weakest was Q4 2014, with a drop of 113436.43 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Atossa Therapeutics | 19.96 Mn | -131.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | -136,901.82% |
| Dec 31, 2014 | -119,018.72% |
| Sep 30, 2014 | -90,986.63% |
| Jun 30, 2014 | -30,974.24% |
| Mar 31, 2014 | -9,475.33% |
| Dec 31, 2013 | -5,582.29% |
| Sep 30, 2013 | -4,410.10% |
| Jun 30, 2013 | -753.09% |
| Mar 31, 2013 | -1,008.64% |
| Dec 31, 2012 | -1,625.51% |
| Sep 30, 2012 | -1,067.61% |
| Jun 30, 2012 | -518.74% |
| Mar 31, 2012 | -1,925.76% |
| Dec 31, 2011 | -79,205.40% |
API Access
Atossa Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();